MaxLinear - MXL Stock Forecast, Price & News

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MaxLinear in the last twelve months. There are currently 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" MXL shares.
View MXL analyst ratings or view top-rated stocks.

8 equities research analysts have issued 12-month price targets for MaxLinear's shares. Their MXL share price forecasts range from $45.00 to $100.00. On average, they predict the company's share price to reach $63.33 in the next year. This suggests a possible upside of 96.1% from the stock's current price.
View analysts price targets for MXL or view top-rated stocks among Wall Street analysts.

MaxLinear's stock was trading at $75.39 at the beginning of the year. Since then, MXL shares have decreased by 57.2% and is now trading at $32.30.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 26th 2022.
View our MXL earnings forecast.

MaxLinear, Inc. (NYSE:MXL) announced its quarterly earnings data on Wednesday, July, 27th. The semiconductor company reported $1.11 EPS for the quarter, beating the consensus estimate of $1.02 by $0.09. The semiconductor company had revenue of $280.01 million for the quarter, compared to the consensus estimate of $279.76 million. MaxLinear had a net margin of 10.08% and a trailing twelve-month return on equity of 46.90%. The firm's quarterly revenue was up 36.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.35 EPS.

MaxLinear issued an update on its third quarter 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $280.00 million-$290.00 million, compared to the consensus revenue estimate of $282.52 million.

56 employees have rated MaxLinear Chief Executive Officer Dr. Kishore Seendripu on Glassdoor.com. Dr. Kishore Seendripu has an approval rating of 90% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other MaxLinear investors own include Energy Transfer (ET), Lamb Weston (LW), Ford Motor (F), Advanced Micro Devices (AMD), RADCOM (RDCM), Alibaba Group (BABA), Intel (INTC), Lumentum (LITE), Micron Technology (MU) and NuStar Energy (NS).

MaxLinear trades on the New York Stock Exchange (NYSE) under the ticker symbol "MXL."

MaxLinear's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Primecap Management Co. CA (4.20%), State Street Corp (3.88%), Millennium Management LLC (3.51%), Price T Rowe Associates Inc. MD (3.05%), Macquarie Group Ltd. (2.86%) and FMR LLC (2.29%). Insiders that own company stock include Brendan Walsh, Connie H Kwong, Connie H Kwong, Curtis Ling, Daniel A Artusi, Donald E Schrock, Eugene A Hall, James Lougheed, Kishore Seendripu, Madhukar Reddy, Michael J Lachance, Steven G Litchfield, Steven G Litchfield, William Kelly Jones and William Torgerson.
View institutional ownership trends.

Shares of MXL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MXL stock can currently be purchased for approximately $32.30.

MaxLinear (NYSE:MXL) has a market capitalization of $2.53 billion and generates $892.40 million in revenue each year. The semiconductor company earns $41.97 million in net income (profit) each year or $1.29 on an earnings per share basis.

The company employs 1,503 workers across the globe.

MaxLinear's mailing address is 5966 LA PLACE COURT SUITE 100, CARLSBAD CA, 92008. The official website for the company is www.maxlinear.com. The semiconductor company can be reached via phone at (760) 692-0711, via email at slitchfield@maxlinear.com, or via fax at 760-444-8598.